Pennsylvania Rescinds Directive that Contract Pharmacies May Not Dispense 340B Drugs to Medicaid Beneficiaries

Pennsylvania Dept. of Human Services medical assistance bulletin image referring to 340B drug pricing program
Pennsylvania rescinded a new Medicaid policy document that said contract pharmacies could not dispense 340B-purchased drugs to Medicaid beneficiaries.

The Pennsylvania Department of Human Services yesterday rescinded Medicaid policy guidance dated Dec. 22 and effective Jan. 1 that forbade 340B covered entities’ contract pharmacies from dispensing 340B-purchased drugs to Medicaid beneficiaries.

The state primary care association warned that the

Read More »

Oregon Bill Targets PBM Policies that Discriminate Against 340B Pharmacies

Oregon House Bill 2716 image
A bill in Oregon would prohibit discriminatory practices by PBMs and insurance plans against 340B pharmacies.

Oregon legislators have introduced a bill that would prohibit discriminatory practices by pharmacy benefit managers and insurance plans against 340B pharmacies, including reimbursing a 340B pharmacy less for prescription drugs compared with non-340B pharmacies. 

If passed later this year, House

Read More »

Federal Court Seals HRSA’s Records in Health Center’s 340B Patient Definition Lawsuit

Genesis Health care facility and signage
The Biden administration will not appeal a high-profile November federal court ruling on the 340B patient definition.

A federal district court in South Carolina yesterday sealed the federal government’s records of the audit, expulsion, and reinstatement of a health center for allegedly diverting 340B-acquired drugs to ineligible patients.

The court order was in Genesis Health Care’s lawsuit

Read More »

340B Recertification for HRSA and Indian Health Service Grantees Starts Jan. 30

Image of a "Certified" stamp
Annual recertification of 340B eligibility for federally qualified health centers and most other grantee-type entities will start Jan. 30 and end Feb. 27.

Annual recertification of 340B eligibility for federally qualified health centers and most other grantee-type entities will start Jan. 30 and end Feb. 27, the U.S. Health Resources and Services Administration said yesterday.

HRSA did not say when Title X family

Read More »

Improve Quality Outcomes with ACOs and 340B

SPONSORED CONTENT

Increasingly, participants in Accountable Care Organizations (ACOs) are discovering and benefiting from the 340B drug discount program. Unlike the historic fee-for-service healthcare models, ACOs are rewarded for outcomes that are better aligned with value-based population health, including improved patient care outcomes, an enhanced patient experience, and more efficient, streamlined provider time where physicians spend more time with patients who are most acute, all while lowering overall costs.

By participating in the 340B program, eligible hospitals and clinics are better positioned to put patient care first. When combined with ACO participation, new drug savings and revenue are generated to further efforts to enhance patient care while lowering costs at a time when the field of healthcare is experiencing unprecedented stressors – both professionally and financially.

Safety-net providers have demonstrated success in accountable care through a collaborative ACO model. In a collaborative, independent providers work together to improve operational efficiencies and quality of care

Read More »

Pennsylvania Says Contract Pharmacies May Not Dispense 340B Drugs to Any Medicaid Beneficiaries

Pennsylvania Dept. of Human Services medical assistance bulletin image referring to 340B drug pricing program
Pennsylvania 340B covered entities are alarmed about the state's position that contract pharmacies may not dispense 340B drugs to any Medicaid beneficiaries.

Pennsylvania 340B health centers and hospitals are alarmed about a Dec. 22 state human services department notice to providers that 340B covered entities’ contract pharmacies “must dispense non-340B-purchased drugs to [Medicaid] beneficiaries in the [fee for service] and managed care

Read More »

340B Market News: Avita Acquires PrEP-by-Telehealth Provider Q Care Plus

QCare+ wordmark
340B contract pharmacy and third-party administration services company Avita has acquired Q Care Plus, a business that helps patients access PrEP by telehealth.

Avita, a leading provider of 340B contract pharmacy and third-party administration services geared toward HIV and LGBTQ+ communities, has acquired Q Care Plus, a business that helps patients access HIV pre-exposure prophylaxis (PrEP) medication by telehealth.

PMQ Investors LLC, Avita’s

Read More »

First 340B-Related Bill of 118th Congress Filed

Screenshot of congress.gov 340B legislation page
The first bill of the 118th Congress to change the 340B program was introduced this week.

U.S. Rep. Matt Rosendale (R-Mont.) has introduced legislation reportedly the same as he filed during the last session of Congress to impose conditions on hospital participation in the 340B program. More bills dealing with 340B are likely.

H.R. 198

Read More »

Nine New Republicans Named to House Committee with 340B Jurisdiction

House E&C wordmark
U.S. House Energy & Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) announced that the panel will have nine new Republicans this session.

U.S. Rep. Cathy McMorris Rodgers (R-Wash.) announced Tuesday that she was named chair of the House Energy & Commerce Committee. She in turn announced yesterday that the House Republican Steering Committee recommended nine new members to serve on the panel.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report